CryoLogyx competing for Ignite Award at SLAS2025

CryoLogyx Ltd, has been named a finalist competing for Ignite Award at SLAS2025 International Conference & Exhibition. Building on its success as the winner of the New Product Award at SLAS2024 Europe in Barcelona, CryoLogyx continues to demonstrate progress in innovation and product differentiation, earning them this global recognition.

CryoLogyx’s patented formulation, CryoShield™, addresses the challenges of traditional cryopreservation methods by integrating nature-inspired soluble ice nucleators, which are easily removed post-thaw, to control ice nucleation and mitigate supercooling effects.

Using CryoShield, cells adhered to microplates remain stable at –80°C for months and can be thawed with standard cell culture media, ready for assays 24 hours post-thaw. Not only is the recovery rate with CryoShield comparable to freshly cultured cells, but cell functions such as metabolic activity, proliferative capacity, and specific hepatic functions are also maintained.

Recognizing the potential of this technology, CryoLogyx launched PlateReady^™, its signature assay ready cells, which in practice require extensive handling, centrifugation, and pipetting. With CryoLogyx’s innovation, cells are provided in the assay ready format, allowing for minimal manipulation and are ready-to-use whenever users need them.

This advancement means that cell culture users can spend more time collecting data instead of spending weeks preparing and culturing cells. The assay ready cells offered by the company are designed for immediate use, speeding up the drug discovery and target validation process. Additionally, this technology has the potential to reduce single-use plastic up to 86% at the point of use and enable broader access to cell models without advanced training. The applications of CryoShield have been expanded to include many sensitive cell types and even spheroids.

CryoLogyx CEO and co-founder, Dr Tom Congdon will be presenting on the topic of Faster, Better, Simpler: Advanced Cryopreservation for Assay Ready Biologics to Streamline High-Throughput Screening during the 14:00 (local time) Ignite session on Monday, January 27. He will be sharing informative data demonstrating the performance of CryoLogyx's innovative solutions across diverse applications.

He said, “We are excited and proud to be selected as an Innovation AveNEW company and finalist of Ignite Award. Our technology ensures that biologics maintain their quality and integrity, allowing researchers to start their experiments without spending time on culturing cells. At SLAS2025, we are excited to present how our solutions make life sciences research faster, better and simpler, while also collaborating with leaders in the industry."

Want the latest science news straight to your inbox? Become a SelectScience member for free today>>